{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:28:37Z","timestamp":1789176517496,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":134,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jtha.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T12:30:58Z","timestamp":1674217858000},"page":"1112-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Genetic determinants of enhanced von Willebrand factor clearance from plasma"],"prefix":"10.1016","volume":"21","author":[{"given":"Omid","family":"Seidizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Pagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Colpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Siboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Biguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.01.012_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.jtha.2023.01.012_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000339426","article-title":"Von Willebrand factor: more than a regulator of hemostasis and thrombosis","volume":"128","author":"Luo","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2023.01.012_bib3","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.046","article-title":"On the versatility of von Willebrand factor","volume":"5","author":"Rauch","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jtha.2023.01.012_bib4","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2023.01.012_bib5","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"Von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"Von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"Von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/a-1334-8002","article-title":"Functional roles of the von Willebrand factor propeptide","volume":"41","author":"Rawley","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2023.01.012_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"Von Willebrand factor clearance - biological mechanisms and clinical significance","volume":"183","author":"O\u2019Sullivan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.01.012_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.jtha.2023.01.012_bib11","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A\u00a0shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib13","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jth.12226","article-title":"Clearance of von Willebrand factor","volume":"11","author":"Casari","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib15","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib16","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib17","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"Von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib19","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib20","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.01.012_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0038-1660481","article-title":"Evaluation of the utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome","volume":"45","author":"Stufano","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jth.15116","article-title":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","volume":"19","author":"Biguzzi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0037-1614063","article-title":"Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease","volume":"84","author":"Baronciani","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2023.01.012_bib25","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/bloodadvances.2020003397","article-title":"Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"5","author":"Baronciani","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.01.012_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH07-09-0565","article-title":"Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations","volume":"99","author":"Millar","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib28","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post-DDAVP in type 1 von Willebrand disease: is it a potential pathogenic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0031-1281039","article-title":"Von Willebrand disease in the United States: a perspective from Wisconsin","volume":"37","author":"Flood","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jth.15713","article-title":"Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program","volume":"20","author":"Christopherson","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib32","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2018-09-874636","article-title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","volume":"133","author":"Aguila","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.01.012_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1538-7836.2009.03381.x","article-title":"Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance","volume":"7","author":"Castaman","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1538-7836.2010.04012.x","article-title":"Von Willebrand factor clearance does not involve proteolysis by ADAMTS-13","volume":"8","author":"Badirou","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jth.12885","article-title":"Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance","volume":"13","author":"Wohner","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3324\/haematol.2017.175216","article-title":"Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor","volume":"103","author":"Wohner","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.01.012_bib38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2009.019927","article-title":"Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia","volume":"95","author":"Casonato","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.01.012_bib39","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1538-7836.2012.04860.x","article-title":"Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages","volume":"10","author":"Castro-N\u00fa\u00f1ez","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib40","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","article-title":"Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in\u00a0vivo","volume":"112","author":"van Schooten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.012_bib41","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in\u00a0vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.01.012_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jth.12875","article-title":"Von Willebrand\u00a0factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in\u00a0vivo","volume":"13","author":"Rawley","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib43","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance","volume":"3","author":"Schooten","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.012_bib44","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1073\/pnas.0705175104","article-title":"Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi","volume":"104","author":"Purvis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:35Z","timestamp":1761536375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1538783623000405"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}